← Open Payments lookup

RICKY MARTIN: Open Payments

NPI 1174880447 · COLUMBUS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,031 in 131 payments from 15 companies in 2025. Trend: 2023 $724 · 2024 $1,310 · 2025 $2,031

Food & beverage: $2,031
CompanyPaymentsAmount
ABBVIE INC.34$529
Takeda Pharmaceuticals U.S.A., Inc.28$377
Madrigal Pharmaceuticals22$300
Salix Pharmaceuticals, a division of Bausch Health US, LLC14$200
Janssen Biotech, Inc.8$174
GENZYME CORPORATION4$105
Ardelyx, Inc.5$91
Phathom Pharmaceuticals, Inc.6$56
Ferring Pharmaceuticals Inc.3$55
Lilly USA, LLC2$47

Products named: REZDIFFRA, ENTYVIO, XIFAXAN, RINVOQ, TREMFYA, DUPIXENT, LINZESS, MAVYRET.

Industry payments across IN — which companies pay providers there.